跳至主要内容
临床试验/NL-OMON50072
NL-OMON50072已完成2 期

Targeting the beta-2 adrenergic pathway to improve skeletal muscle glucose uptake in healthy humans - Human Beta-2 Adrenergic Stimulation and Muscle Glucose Uptake

niversiteit Maastricht0 个研究点目标入组 23 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Caucasian;
  • 2. Male sex;
  • 3. Age: 18-30 years
  • 4. BMI: 20-25 kg/m2;
  • 5. Normal physical activity levels;

排除标准

  • 1. Not meeting all inclusion criteria
  • 2. Cardiovascular disease (determined by means of questionnaires, heart
  • rate/blood pressure measurements and an ECG);
  • 3. Respiratory diseases (including asthma, bronchitis and COPD);
  • 4. Unstable body weight (weight gain or loss > 5 kg in the last three months);
  • 5. Intention to lose or gain body weight (e.g. with caloric restriction or
  • physical activity)
  • 6. Excessive alcohol and/or drug abuse;
  • 7. Hypokalaemia;
  • 8. Anaemia;
  • 9. Epilepsy;
  • 10. Smoking;
  • 11. Renal and/or liver insufficiency;
  • 12. Participation in another biomedical study within 1 month before the first
  • study visit, possibly interfering with the study results;
  • 13. Medication use known to hamper subject*s safety during the study
  • procedures; *
  • 14. Subjects who do not want to be informed about unexpected medical findings; *
  • 15. Subjects who do not want that their treating physician to be informed;
  • 16. Inability to participate and/or complete the required measurements;
  • 17. Participation in organised or structured physical exercise;
  • 18. Any condition, disease or abnormal laboratory test result that, in the
  • opinion of the Investigator, would interfere with the study outcome, affect
  • trial participation or put the subject at undue risk;
  • 19. Hyperthyroidism

研究者

相似试验